BG Medicine, Inc. (OTCMKTS:BGMD) shares were down 31.5% on Thursday . The company traded as low as $0.01 and last traded at $0.02, approximately 2,125 shares traded hands during mid-day trading. A decline of 66% from the average daily volume of 6,317 shares. The stock had previously closed at $0.02.
The company’s 50 day moving average is $0.02.
BG Medicine Company Profile (OTCMKTS:BGMD)
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Read More: Understanding Analyst Recommendations
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.